IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Palo Alto Investors LP

Portfolio Profile

CIK: 0001306923 | PALO ALTO, CA

Investment Profile

Style

Core

Turnover

Medium

Orientation

Concentrated trader
$723.7M
AUM
52
Positions
61.28%
Top 10 Conc.
91.65%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1PTC Therapeutics Inc(PTCT)918,846$75.0M10.36%
2Acadia Pharmaceuticals Inc(ACAD)2,864,096$72.5M10.01%
3Insmed Inc(INSM)413,980$44.1M6.10%
4Mirum Pharmaceuticals Inc(MIRM)348,808$40.8M5.64%
5Anaptysbio Inc(ANAB)603,489$40.7M5.63%
6

Sector Allocation

Latest filing, equity positions only

Healthcare93.11% · $673.9M
Unclassified6.58% · $47.6M
Financial Services0.31% · $2.2M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare95.37%93.11%-2.26%
Unclassified4.33%6.58%+2.25%

AUM History

$1.1B | 29 pos.
$1.1B | 34 pos.
$886.7M | 38 pos.
$863.0M | 39 pos.
$769.9M | 45 pos.
$645.4M | 43 pos.
Biomarin Pharmaceutical Inc(BMRN)
682,777
$39.1M
5.40%
7Dyne Therapeutics Inc(DYN)1,647,521$36.6M5.06%
8United Therapeutics Corp(UTHR)62,587$33.9M4.69%
9Disc Medicine Inc(IRON)416,646$30.5M4.21%
10Biogen Inc(BIIB)140,279$30.3M4.19%
Financial Services0.29%0.31%+0.02%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

Cap SizePrev %Curr %Change
Mid Cap41.87%41.77%-0.1%
Small Cap24.84%28.03%+3.19%
Large Cap28.33%22.55%-5.78%
Unclassified4.33%6.58%+2.25%
Micro Cap0.63%1.07%+0.44%
$525.1M | 44 pos.
$470.0M | 45 pos.
$540.4M | 44 pos.
$718.4M | 49 pos.
$653.9M | 51 pos.
$723.7M | 52 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

3
New
2
Closed
5
Increased
15
Decreased
29
Unchanged